Comprehensive access support
Janssen is dedicated to making XARELTO® affordable and accessible for all patients. With widespread inclusion on hospital, managed care, and PBM formularies, >95% of commercial and Medicare patients are covered at the lowest branded co-pay.1
To see the coverage for your patients, enter your ZIP code. Your results will appear below.
Tier 2: For most plans, brand-name drugs that are generally covered at lower co-payments than Tier 3 brand-name drugs. (Tier 1 drugs generally are generic drugs and have the lowest co-payments.)
Preferred: For most plans, brand-name drugs that are generally covered at “preferred” or lower co-payments than Tier 3 brand-name drugs. (Tier 1 drugs generally are generic drugs and have the lowest co-payments.)
Tier 3 Preferred: For the plans listed, brand-name drugs that are generally covered at lower co-payments than higher tier brand-name drugs. (Tiers 1 and 2 are reserved for generic drugs.)
Tier 3: For most plans, brand-name drugs that are generally covered at higher co-payments than Tier 2 brand-name drugs.
Tier 4: For most plans, brand-name drugs that are generally covered at higher co-payments than Tier 2 and Tier 3 brand-name drugs.
Covered: For most plans, reimbursable, but at a higher co-payment than the preferred formulary product.
PA: Prior Authorization is required.
ST: Step therapy is required.
The information provided represents no statement, promise, or guarantee by Janssen Pharmaceuticals, Inc., concerning coverage, levels of reimbursement, payment, or charge. Nothing herein may be construed as an endorsement, approval, recommendation, representation, or warranty of any kind. This communication is solely the responsibility of Janssen Pharmaceuticals, Inc. Please consult your payer organization with regard to local or actual coverage, and reimbursement policies and determination processes.
All information is subject to change. Data last updated 12/1/16.
Janssen CarePath Savings Card for XARELTO®
$0 co-pay every month* for patients with commercial insurance
Eligible patients with an approved chronic indication for XARELTO® (15 mg or 20 mg)
Per calendar year, subject to $3400 maximum annual program benefit. No monthly cap
For eligibility requirements and restrictions, visit Janssen CarePath or call 877-CarePath (877-227-3728). A Janssen CarePath Trial Offer for XARELTO® Trial Offer may also be available.
*Not valid for patients enrolled in Medicare Part D or Medicaid. Certain restrictions apply.
Janssen CarePath Trial Offer for XARELTO®
Assistance for patients with federally funded Medicare, Medicaid, TRICARE, or commercial insurance
Eligible patients with an approved chronic indication for XARELTO® (15 mg or 20 mg) will receive up to a free 30-day supply
Subject to 1 use or 12 months from program start date, whichever comes first
For eligibility requirements and restrictions, call 877-CarePath (877-227-3728).
Other Patient Assistance Resources
Assistance for patients with no insurance
Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is committed to providing access to uninsured individuals who lack the financial resources to pay for their medicines.
If your patient needs XARELTO® and is uninsured and unable to pay for their medicine, and you would like to see if they might qualify for assistance, please have them:
contact a JJPAF program specialist at 1-800-652-6227, 9:00 AM-6:00 PM ET, or
visit the Foundation website
If a patient does not have coverage for XARELTO®, a comprehensive list of additional programs is available at Janssen Prescription Assistance.